📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
HCG to Announce Q3 & 9M FY26 Results on Feb 5; Earnings Call Scheduled for Feb 9
Healthcare Global Enterprises Limited (HCG) has announced that its Board of Directors will meet on February 5, 2026, to approve the unaudited financial results for the quarter and nine months ended December 31, 2025. Subsequently, an earnings conference call is scheduled for February 9, 2026, at 12:00 PM IST to discuss the performance. The call will feature senior management discussing the results of HCG's network, which includes 22 cancer centers and 7 fertility centers. This is a routine but essential update for shareholders to track the company's financial health and operational progress.
Key Highlights
Board meeting to approve Q3 and 9M FY26 financial results scheduled for February 5, 2026
Earnings conference call for analysts and investors set for February 9, 2026, at 12:00 PM IST
HCG operates a significant network of 22 comprehensive cancer centers across India and Africa
Company also manages 7 fertility centers under the Milann brand
Management discussion will be followed by an interactive Q&A session for participants
💼 Action for Investors
Investors should monitor the financial results on February 5 for margin trends and oncology volume growth, and consider attending the call on February 9 for management's future guidance.